Lantheus Holdings, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Lantheus Holdings, Inc. (LNTH) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$567.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-26
- Lantheus Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was -$567.00K.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was -$1.95M, a 135.93% decline from fiscal 2022.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was $5.42M, a 63.89% decline from fiscal 2021.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2021 was $15.02M, a 6428.26% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2024-12-31 | -$567.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | -$1.95M 10-K · filed 2026-02-26 |
| 2022-12-31 | $5.42M 10-K · filed 2025-02-26 |
| 2021-12-31 | $15.02M 10-K · filed 2024-02-22 |
| 2020-12-31 | $230.00K 10-K · filed 2023-02-23 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |